Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Filing tables
Filing exhibits
Motif Bio similar filings
Filing view
External links
Exhibit 15.3
CONSENT OF BAL PHARMA CONSULTING, LLC
BAL Pharma Consulting, LLC hereby consents to all references to the market research survey we were commissioned to prepare on behalf of Motif Bio plc entitled “Assessment of Iclaprim Commercial Opportunity in the Gram Positive Antibiotic Hospital Market” and to the results of such survey included in this Annual Report on Form 20-F of Motif Bio plc for the year ending December 31, 2016, and to all references to BAL Pharma Consulting, LLC as having prepared such survey.
/s/ Lynda Berne |
|
Lynda Berne |
|
Principal |
|
BAL Pharma Consulting, LLC |
|
April 24, 2017 |
|